Navigation Links
WuXi PharmaTech Announces Second-Quarter 2012 Results
Date:8/13/2012

uesday, August 14, 2012, to discuss its second-quarter 2012 financial results and future prospects.  The conference call may be accessed by calling:

United States:

1-866-519-4004China (Landline):800-819-0121China (Mobile):

400-620-8038Hong Kong:

800-930-346United Kingdom:0-808-234-6646International:+65-6723-9381Conference ID:10406942A telephone replay will be available two hours after the call's completion at:

United States:

1-866-214-5335China (Landline):10-800-714-0386China (Mobile):

10-800-140-0386Hong Kong:

800-901-596United Kingdom:0-800-731-7846International:+61-2-8235-5000Conference ID:10406942A live webcast of the conference call and replay will be available on the investor relations page of WuXi PharmaTech's website at http://www.wuxiapptec.com.

About WuXi PharmaTechWuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please visit: http://www.wuxiapptec.com

Use of Non-GAAP and Pro-Forma Financial Measures  We have provided the second-quarter 2011 and 2012 gross profit, gross margin, operating income, operating margin, net income, net margin, and earnings per ADS on a non-GAAP basis, which excludes share-based compensation expenses and amortization and deferred tax impact of acquired intangible assets. We believe both ma
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
2. WuXi PharmaTech Announces First-Quarter 2012 Results
3. Industry Leading Pharmaceutical News Website in-Pharmatechnologist.com Refocused and Relaunched
4. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
5. Varian Medical Systems CEO Timothy E. Guertin Announces Plans to Retire; Board of Directors Names Dow R. Wilson as Successor
6. Comprehensive Care Corporation Announces Profitable Six Month Financial Results
7. Tactical Medical Packs Announces New Disaster Medical Packs Equipping First Responders for Mass Casualty Incidents
8. Echo Therapeutics Announces Second Quarter 2012 Financial Results
9. Bacterin International Announces Second Quarter and Six Months 2012 Financial Results
10. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
11. 3SBio Inc. Announces Changes to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Inc. (NASDAQ: NWBO )("NW Bio"), a U.S. biotechnology ... solid tumor cancers, announced today that CEO Linda Powers ... Immunotherapy Forum in Washington D.C. ... January 26 at 10:30 a.m. EST at the Grand Hyatt ...
(Date:1/23/2015)... , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( ... of directors of Advaxis, Inc. ("Advaxis" or the "Company") ... has breached its fiduciary duties to shareholders. ... an investing website reporting that Advaxis had misrepresented the ...
(Date:1/23/2015)... , Jan. 23, 2015  iMD Companies, Inc. (ICBU) has repositioned ... market share and grab a foothold in the hydroponic, hemp ... capabilities and a presence in the sector, and recently partnering ... growth of hemp and medical marijuana, iMD is committing to ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... Inc. (NYSE: MTD ) today announced the webcast ... in New York on Wednesday, September 21, 2011, at 9:00 ... presentation, visit the investor relations page on the Company,s Web ... will be available for seven days. METTLER TOLEDO ...
... JERUSALEM, Sept. 14, 2011 Chiasma, Inc., a privately held ... will present an overview of the Company at the UBS ... New York, on Monday, September 19, 2011 at 1:30 PM. ... form of octreotide acetate being developed first for the oral ...
Cached Medicine Technology:Chiasma to Present at the UBS Global Life Sciences Conference 2
(Date:1/22/2015)... January 22, 2015 The Incredible Bulk is ... Pakulski to increase lean muscle by up to 30lbs in ... the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. ... is a step-by-step, scientific diet formula that allows the body ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District ... against C.R. Bard, Inc. in that proceeding’s first bellwether trial. ... defense request for a new trial after finding that C.R. ...
(Date:1/22/2015)... released a new blog post explaining the main features of ... Auto insurance quotes help many drivers find the best coverage ... an agent or visit an agency for price information. These ... http://autocarinsurancebest.com/ . , Every business who relies heavily on transportation ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
(Date:1/22/2015)... Boulder, Colorado (PRWEB) January 22, 2015 Four years ... is Queen – which coincided with the marriage of Avasa & ... album, THE ROAD, which is scheduled for release through White Swan ... heartfelt message that there is a sacred path available to all ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... News) -- Poor growth, heart problems and delays in ... mild to moderately impaired kidney function, new research says. ... disease also found that even when some of them ... blood pressure and metabolic issues, the conditions became more ...
... News) -- The U.S. Food and Drug Administration on ... for the treatment of an often lethal form of melanoma. ... in about half of melanomas, the deadliest form of skin ... fight against metastatic melanoma and the advancement of treatment for ...
... reduce health care costs arising from pressure ulcers, commonly ... elderly patients in emergency departments, according to new research ... elderly patients are at high risk for pressure ulcers ... surfaces. The researchers found that while the average cost ...
... , WEDNESDAY, Aug. 17 (HealthDay News) -- Researchers have ... in identifying women who have a higher risk of ... This particular antibody, which was detected in blood, develops ... mesothelin. This protein is present in advanced ovarian cancer. ...
... spent annually on treating chronic wounds on patients in the ... life of more than six million people who have them. ... ulcers are related to venous disease (conditions related to or ... options are available, but the quality of evidence showing which ...
... HealthDay Reporter , TUESDAY, Aug. 16 (HealthDay ... with bipolar disorder are better controlled by antipsychotic ... suggests. Researchers from Italy and the United ... haloperidol (Haldol) along with later formulations of risperidone ...
Cached Medicine News:Health News:FDA Approves Novel Melanoma Drug 2Health News:FDA Approves Novel Melanoma Drug 3Health News:Better mattresses improve care, cut hospital costs: U of T study 2Health News:Blood Antibody May Signal Start of Ovarian Cancer 2Health News:Blood Antibody May Signal Start of Ovarian Cancer 3Health News:Johns Hopkins Evidence-based Practice Center awarded $475,000 project 2Health News:Johns Hopkins Evidence-based Practice Center awarded $475,000 project 3Health News:Antipsychotics Best for Controlling Mania: Study 2Health News:Antipsychotics Best for Controlling Mania: Study 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: